| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | respiratory failure | 2.42e-05 | 165 | 30 | 5 | MP:0001953 | |
| MousePheno | decreased respiration | 2.79e-05 | 170 | 30 | 5 | MP:0014274 | |
| Domain | HLH | 9.79e-04 | 111 | 33 | 3 | PF00010 | |
| Domain | HLH | 1.11e-03 | 116 | 33 | 3 | SM00353 | |
| Domain | BHLH | 1.14e-03 | 117 | 33 | 3 | PS50888 | |
| Domain | bHLH_dom | 1.17e-03 | 118 | 33 | 3 | IPR011598 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 4.91e-04 | 18 | 26 | 2 | M3430 | |
| Pathway | WP_NEPHROGENESIS | 4.91e-04 | 18 | 26 | 2 | M40045 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 4.91e-04 | 18 | 26 | 2 | MM1385 | |
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 10391891 | ||
| Pubmed | Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. | 1.10e-05 | 5 | 37 | 2 | 23903657 | |
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 1.10e-05 | 5 | 37 | 2 | 11701968 | |
| Pubmed | 1.10e-05 | 5 | 37 | 2 | 31376680 | ||
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 1.65e-05 | 6 | 37 | 2 | 18159949 | |
| Pubmed | 3.07e-05 | 8 | 37 | 2 | 19339282 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 4.20e-05 | 908 | 37 | 7 | 19274049 | |
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 23119100 | ||
| Pubmed | 5.91e-05 | 650 | 37 | 6 | 38777146 | ||
| Pubmed | 7.16e-05 | 209 | 37 | 4 | 36779422 | ||
| Pubmed | Large-scale genotyping identifies 41 new loci associated with breast cancer risk. | 7.39e-05 | 76 | 37 | 3 | 23535729 | |
| Pubmed | 8.53e-05 | 13 | 37 | 2 | 31070778 | ||
| Pubmed | 1.15e-04 | 15 | 37 | 2 | 34155146 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.31e-04 | 16 | 37 | 2 | 19922871 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.56e-04 | 256 | 37 | 4 | 33397691 | |
| Pubmed | 1.86e-04 | 19 | 37 | 2 | 16844427 | ||
| Pubmed | 1.94e-04 | 808 | 37 | 6 | 20412781 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 2.28e-04 | 21 | 37 | 2 | 33029523 | |
| Pubmed | 3.25e-04 | 25 | 37 | 2 | 21518438 | ||
| Pubmed | 3.80e-04 | 27 | 37 | 2 | 32878924 | ||
| Pubmed | 5.33e-04 | 634 | 37 | 5 | 34591612 | ||
| Pubmed | 8.76e-04 | 708 | 37 | 5 | 39231216 | ||
| Pubmed | 1.06e-03 | 45 | 37 | 2 | 22696295 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 8.81e-04 | 54 | 37 | 2 | chr3q11 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.84e-04 | 16 | 23 | 2 | 14 | |
| GeneFamily | Basic helix-loop-helix proteins | 8.54e-03 | 110 | 23 | 2 | 420 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 1.02e-05 | 291 | 37 | 6 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000 | 9.56e-05 | 633 | 37 | 7 | gudmap_kidney_P1_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | 9.85e-05 | 636 | 37 | 7 | gudmap_kidney_P2_CapMes_Crym_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 1.49e-04 | 294 | 37 | 5 | gudmap_kidney_P0_CapMes_Crym_500 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | 3.91e-07 | 181 | 37 | 5 | 9b33f531c8ac776706ec7e2d47e95ba30b6ce13c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.91e-07 | 181 | 37 | 5 | a0549a8c2b5b30e91fae3052f398e48baa45d7ff | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.36e-07 | 185 | 37 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.48e-07 | 186 | 37 | 5 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.25e-07 | 199 | 37 | 5 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.48e-06 | 140 | 37 | 4 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 173 | 37 | 4 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 173 | 37 | 4 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 173 | 37 | 4 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 179 | 37 | 4 | 69c74b2ff43b43653005807654953daf21f932ec | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 189 | 37 | 4 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.79e-05 | 189 | 37 | 4 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | CV-Healthy-0|CV / Virus stimulation, Condition and Cluster | 1.82e-05 | 190 | 37 | 4 | 559e6c18b938aa41856358a2087f33b0a1b7b245 | |
| ToppCell | CV-Healthy|CV / Virus stimulation, Condition and Cluster | 1.94e-05 | 193 | 37 | 4 | 0387ee691be9e3ea720ea67f6fa02eb6d58609e3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.94e-05 | 193 | 37 | 4 | 024d30eb143d8278c0851c3a6c9426226fa3b480 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 195 | 37 | 4 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.10e-05 | 197 | 37 | 4 | 66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-05 | 197 | 37 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 197 | 37 | 4 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 197 | 37 | 4 | ad6c200a193a15360d17463e18a465ce1b90b8da | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 198 | 37 | 4 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 198 | 37 | 4 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 198 | 37 | 4 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | Control-B_intermediate-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.14e-05 | 198 | 37 | 4 | 97e66b845053201247e2241739328cd73f33975c | |
| ToppCell | Control-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.14e-05 | 198 | 37 | 4 | 6f7e0b8bc06368d6e7026d69473ddd42dd41cfcb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 37 | 4 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-05 | 199 | 37 | 4 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-05 | 199 | 37 | 4 | a95aa72387c9558e0316898eaa9df4de8932af1b | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 5a29db2610ba06a2248325a16cad755d20debf2c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 5fc9bd5740e2e4d657c8c3dd26567db9a6da5af8 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.19e-05 | 199 | 37 | 4 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.67e-04 | 129 | 37 | 3 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-04 | 137 | 37 | 3 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 143 | 37 | 3 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 155 | 37 | 3 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 156 | 37 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-04 | 165 | 37 | 3 | 01c6355177d79b4523c8b20366e20b2b62c6d08d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-04 | 167 | 37 | 3 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.56e-04 | 167 | 37 | 3 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.56e-04 | 167 | 37 | 3 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.68e-04 | 169 | 37 | 3 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 169 | 37 | 3 | 49a54fb2ea9db5c45e107f304838c536908308bb | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Brain / Location, Cell class and cell subclass | 3.81e-04 | 171 | 37 | 3 | d3e1cc1b70256c4d01488d6b6130bbcae99bdeec | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 171 | 37 | 3 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 171 | 37 | 3 | d6d8ea45b443d95f64720c9bc07d324148f5b239 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 172 | 37 | 3 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-04 | 173 | 37 | 3 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 173 | 37 | 3 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-04 | 173 | 37 | 3 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-04 | 173 | 37 | 3 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 174 | 37 | 3 | 9eab43885496b8586f8ec5b4bcb1fd5b209218e5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 174 | 37 | 3 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.08e-04 | 175 | 37 | 3 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.08e-04 | 175 | 37 | 3 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 175 | 37 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-04 | 176 | 37 | 3 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-04 | 176 | 37 | 3 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 4.22e-04 | 177 | 37 | 3 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 4.22e-04 | 177 | 37 | 3 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.22e-04 | 177 | 37 | 3 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.29e-04 | 178 | 37 | 3 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.29e-04 | 178 | 37 | 3 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.29e-04 | 178 | 37 | 3 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.29e-04 | 178 | 37 | 3 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | Children_(3_yrs)|World / Lineage, Cell type, age group and donor | 4.29e-04 | 178 | 37 | 3 | df2ecd3214590b914f2762db57efe780ba038db3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 181 | 37 | 3 | d90faa6115b408c9fbca61fc90ff951e070754ba | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 4.57e-04 | 182 | 37 | 3 | cd6e3a9f4eb4fe73b28da61d1d35c64fd9ffa892 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.57e-04 | 182 | 37 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | 4.65e-04 | 183 | 37 | 3 | ab5aaafcfd7b97330be6774be4c72611ca85257c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-04 | 183 | 37 | 3 | 9ca4954faaba50466c35121d6765895e955178aa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-04 | 183 | 37 | 3 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-04 | 183 | 37 | 3 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-04 | 183 | 37 | 3 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | 4.65e-04 | 183 | 37 | 3 | 193bfb787c1b36c8fabf4b00fafb5b398de6b999 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.72e-04 | 184 | 37 | 3 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.72e-04 | 184 | 37 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.79e-04 | 185 | 37 | 3 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.79e-04 | 185 | 37 | 3 | 48de4d9fad55077732bf64eca4919103ecbc1512 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.79e-04 | 185 | 37 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.87e-04 | 186 | 37 | 3 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-04 | 186 | 37 | 3 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|normal_Lung / Location, Cell class and cell subclass | 4.87e-04 | 186 | 37 | 3 | 0987c9a39503eb6c75a2bf4db98b2b2fd46956fb | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-04 | 186 | 37 | 3 | ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.87e-04 | 186 | 37 | 3 | 00ad1239b952119b3fd2e6af8f034cba3488f9c1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.95e-04 | 187 | 37 | 3 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | 1669df899b1759c338ffce196fe009840123cfcd | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-04 | 187 | 37 | 3 | 39756ab418267151d86f9c2553db859f71900bb1 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.02e-04 | 188 | 37 | 3 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.02e-04 | 188 | 37 | 3 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.02e-04 | 188 | 37 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.02e-04 | 188 | 37 | 3 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 5.10e-04 | 189 | 37 | 3 | f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 5.10e-04 | 189 | 37 | 3 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 6.47e-07 | 199 | 36 | 6 | 6950_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.23e-05 | 192 | 36 | 5 | 6207_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.36e-05 | 196 | 36 | 5 | 4711_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 6935_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 6230_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 7206_DN | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.47e-05 | 199 | 36 | 5 | 5302_DN | |
| Drug | Promegestone | 3.71e-05 | 41 | 36 | 3 | ctd:D011397 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.19e-04 | 161 | 36 | 4 | 3556_DN | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.20e-04 | 189 | 36 | 4 | 4401_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 2634_DN | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.34e-04 | 192 | 36 | 4 | 3164_DN | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 6920_UP | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 6946_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; HL60; HG-U133A | 2.38e-04 | 193 | 36 | 4 | 1380_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 6995_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 4559_DN | |
| Drug | 5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 2.48e-04 | 195 | 36 | 4 | 944_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 3503_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 6926_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA | 2.48e-04 | 195 | 36 | 4 | 989_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 5245_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 1182_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 7423_UP | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; HL60; HG-U133A | 2.53e-04 | 196 | 36 | 4 | 2043_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 7187_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 6236_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 6988_DN | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 5331_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 5060_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 6227_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 5669_DN | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 7064_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6412_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6941_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 5106_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2307_DN | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 4009_DN | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6216_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2934_UP | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 1693_DN | |
| Drug | testosterone enanthate | 2.58e-04 | 575 | 36 | 6 | ctd:C004648 | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6777_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.63e-04 | 198 | 36 | 4 | 996_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 2633_DN | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 2640_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 1689_DN | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 5266_DN | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4979_DN | |
| Drug | Bisoprolol fumarate; Down 200; 9uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 5348_DN | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 6252_DN | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4808_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 3410_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 4523_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 7217_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 7212_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HG-U133A | 2.68e-04 | 199 | 36 | 4 | 337_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 7219_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 2.68e-04 | 199 | 36 | 4 | 984_DN | |
| Drug | dicyclohexyl phthalate | 2.89e-04 | 836 | 36 | 7 | ctd:C036042 | |
| Disease | coronary artery disease (is_implicated_in) | 1.91e-04 | 100 | 33 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | diastolic blood pressure, alcohol drinking | 3.12e-04 | 118 | 33 | 3 | EFO_0004329, EFO_0006336 | |
| Disease | systolic blood pressure, alcohol drinking | 3.96e-04 | 128 | 33 | 3 | EFO_0004329, EFO_0006335 | |
| Disease | serum gamma-glutamyl transferase measurement | 4.70e-04 | 914 | 33 | 6 | EFO_0004532 | |
| Disease | Diuretic use measurement | 8.87e-04 | 169 | 33 | 3 | EFO_0009928 | |
| Disease | Anorectal Malformations | 9.68e-04 | 41 | 33 | 2 | C3495676 | |
| Disease | systolic blood pressure, alcohol consumption measurement | 1.27e-03 | 47 | 33 | 2 | EFO_0006335, EFO_0007878 | |
| Disease | Calcium channel blocker use measurement | 1.72e-03 | 213 | 33 | 3 | EFO_0009930 | |
| Disease | urate measurement, spine bone mineral density | 1.93e-03 | 58 | 33 | 2 | EFO_0004531, EFO_0007701 | |
| Disease | pulse pressure measurement, alcohol drinking | 2.79e-03 | 70 | 33 | 2 | EFO_0004329, EFO_0005763 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.96e-03 | 286 | 33 | 3 | EFO_0004346, EFO_0006930 | |
| Disease | Alzheimer disease, polygenic risk score | 3.99e-03 | 586 | 33 | 4 | EFO_0030082, MONDO_0004975 | |
| Disease | Inguinal hernia | 4.00e-03 | 287 | 33 | 3 | HP_0000023 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 4.57e-03 | 90 | 33 | 2 | DOID:11832 (biomarker_via_orthology) | |
| Disease | mean arterial pressure, alcohol drinking | 5.39e-03 | 98 | 33 | 2 | EFO_0004329, EFO_0006340 | |
| Disease | neurotic disorder | 5.72e-03 | 101 | 33 | 2 | EFO_0004257 | |
| Disease | corneal topography | 6.63e-03 | 109 | 33 | 2 | EFO_0004345 | |
| Disease | Beta blocking agent use measurement | 7.22e-03 | 114 | 33 | 2 | EFO_0009929 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQQGQEDGQQKKARA | 1091 | Q5SNV9 | |
| NNEVVGKGRNEVNQT | 51 | Q7Z6V5 | |
| EQGKRFQSINHNEIG | 881 | Q68DQ2 | |
| QHYQQQQQVAGGALG | 151 | Q7RTS1 | |
| GGTGSQQRVQGKHQV | 1131 | O15085 | |
| EQIETQGQVNHNGQK | 296 | Q3SXY8 | |
| GRQQNPVVNNHIGGK | 666 | Q9UL03 | |
| QQQQQQKGGRGAAAG | 316 | O14979 | |
| SEEENVGHQQAGNVK | 81 | Q6NTE8 | |
| QKHQQDEGQGGLNNE | 11 | Q86X51 | |
| RQNQGEGQHLQNSFK | 1011 | Q9P219 | |
| QEQKQEQGARLGRNH | 1021 | O95382 | |
| GGSRLQVHQKQQLQG | 151 | Q14766 | |
| EQQHLKGQTGTNGGN | 166 | P04150 | |
| VHLGVKGQVFDQNGN | 311 | P14384 | |
| ANGQENGHVKVNGDA | 31 | P29966 | |
| QRPEQRQQHEGAQGA | 86 | P33241 | |
| NAIKVNNVNGNQVGH | 96 | Q14527 | |
| GQAGKELQNAHNGVN | 521 | Q6UWP8 | |
| RRKGQQQQQQQGTVG | 241 | Q2MKA7 | |
| QREQQQQQPHGVDGK | 511 | P35712 | |
| HFQEGRRAQQQLENG | 116 | Q15642 | |
| HVNGEQENRVQKGNG | 491 | Q8TAF3 | |
| QNQGKKAEGAQNQGQ | 496 | Q9P2E9 | |
| GNDFGNDRNHRNQVE | 81 | O60224 | |
| GEYLQQQQQHGNGAV | 31 | Q02447 | |
| QKEQEQVRATSQGGH | 406 | A8MWX3 | |
| EVGGHQERQQAGAQG | 1056 | Q9C0C2 | |
| QKGNLVQHQRGHTGE | 391 | Q8TAU3 | |
| QKEQEQVRATSQGGH | 391 | C4AMC7 | |
| GVSQEGKQVQRNAAN | 71 | O43680 | |
| MHQQQDVGSRQQGSG | 1601 | Q68DE3 | |
| SQGVDHKQVQRELGN | 661 | Q9Y6N7 | |
| REAQEQQNDGKGRGN | 1551 | Q9Y6N7 | |
| HLQQQQKGGGGSQIN | 136 | P47974 | |
| LDQNVININHQGRDG | 326 | Q59H18 | |
| KNNQVGDQAQGIHRH | 196 | Q7Z570 | |
| NEAHVLNGINDRGGQ | 141 | Q92802 |